Vimarsana
Biggest News Aggregation in the World

Page 2 - Mark Rus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Rus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Rus Today - Breaking & Trending Today

Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability - Vimarsana News

Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability

/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and...

Delix Therapeutics Expands World-Class Team with First Head of R&D - Vimarsana News

Delix Therapeutics Expands World-Class Team with First Head of R&D

/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological...

Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up - Vimarsana News

Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up

/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological...

Delix Therapeutics Closes $30M Convertible Note Financing - Vimarsana News

Delix Therapeutics Closes $30M Convertible Note Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million Strategic Credit Facility Option in Partnership with Comerica Bank - Vimarsana News

Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million Strategic Credit Facility Option in Partnership with Comerica Bank

/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological...